Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial

類似資料

• Beta Agonist Lung Injury TrIal-2 (BALTI-2) trial protocol: A randomised, double-blind, placebo-controlled of intravenous infusion of salbutamol in the acute respiratory distress syndrome
  著者:: Perkins, Gavin D, 等
  出版事項: (2011)
• Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome
  著者:: S Gates, 等
  出版事項: (2013-09-01)
• Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome.
  著者:: Gates, S, 等
  出版事項: (2013)
• Bench-to-bedside review: β(2)-Agonists and the acute respiratory distress syndrome
  著者:: Perkins, Gavin D, 等
  出版事項: (2003)
• Reply: Importance of the Kidney, Vessels, and Heart with Administration of β(2) Adrenergic Receptor Agonists in Patients Susceptible to Acute Respiratory Distress Syndrome
  著者::  Thickett, David R., 等
  出版事項: (2014)